Literature DB >> 17640968

Protease-activated receptor-2 augments experimental crescentic glomerulonephritis.

Leon Moussa1, Jim Apostolopoulos, Piers Davenport, Jorge Tchongue, Peter G Tipping.   

Abstract

Protease-activated receptor-2 (PAR-2) is a cellular receptor expressed prominently on epithelial, mesangial, and endothelial cells in the kidney and on macrophages. PAR-2 is activated by serine proteases such as trypsin, tryptase, and coagulation factors VIIa and Xa. It induces pleiotropic effects including vasodilatation, increasing plasminogen activator inhibitor (PAI-1) expression, mesangial cell proliferation, and cytokine production by macrophages. The role of PAR-2 in renal inflammation was studied in antiglomerular basement membrane antibody-induced crescentic glomerulonephritis (CGN) using PAR-2-deficient (PAR-2(-/-)) mice and wild-type littermate controls. PAR-2(-/-) mice had reduced crescent formation, proteinuria, and serum creatinine compared with wild-type mice 21 days after initiation of CGN. Glomerular accumulation of CD4(+) T cells and macrophages and the number of proliferating cells in glomeruli were similar in both groups. Glomerular fibrin deposition was significantly reduced in PAR-2(-/-) mice, and this was associated with reduced renal plasminogen activator inhibitor expression and increased renal matrix-metalloprotinase-9 activity. These results demonstrate a proinflammatory role for PAR-2 in CGN that is independent of effects on glomerular leukocyte recruitment and mesangial cell proliferation. PAR-2-mediated augmentation of renal plasminogen activator inhibitor expression and inhibition of matrix-metalloprotinase-9 activity may contribute to increased glomerular fibrin accumulation and glomerular injury in CGN.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17640968      PMCID: PMC1959493          DOI: 10.2353/ajpath.2007.061155

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  56 in total

Review 1.  Proteinase-activated receptors: novel mechanisms of signaling by serine proteases.

Authors:  O Déry; C U Corvera; M Steinhoff; N W Bunnett
Journal:  Am J Physiol       Date:  1998-06

2.  Antibody independent crescentic glomerulonephritis in mu chain deficient mice.

Authors:  S Li; S R Holdsworth; P G Tipping
Journal:  Kidney Int       Date:  1997-03       Impact factor: 10.612

3.  Tissue factor initiates glomerular fibrin deposition and promotes major histocompatibility complex class II expression in crescentic glomerulonephritis.

Authors:  J H Erlich; S R Holdsworth; P G Tipping
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

4.  Characterization of protease-activated receptor-2 immunoreactivity in normal human tissues.

Authors:  M R D'Andrea; C K Derian; D Leturcq; S M Baker; A Brunmark; P Ling; A L Darrow; R J Santulli; L F Brass; P Andrade-Gordon
Journal:  J Histochem Cytochem       Date:  1998-02       Impact factor: 2.479

5.  Interactions of mast cell tryptase with thrombin receptors and PAR-2.

Authors:  M Molino; E S Barnathan; R Numerof; J Clark; M Dreyer; A Cumashi; J A Hoxie; N Schechter; M Woolkalis; L F Brass
Journal:  J Biol Chem       Date:  1997-02-14       Impact factor: 5.157

6.  Crescentic glomerulonephritis in CD4- and CD8-deficient mice. Requirement for CD4 but not CD8 cells.

Authors:  P G Tipping; X R Huang; M Qi; G Y Van; W W Tang
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

7.  Thrombin and trypsin-induced Ca(2+) mobilization in human T cell lines through interaction with different protease-activated receptors.

Authors:  B Mari; S Guerin; D F Far; J P Breitmayer; N Belhacene; J F Peyron; B Rossi; P Auberger
Journal:  FASEB J       Date:  1996-02       Impact factor: 5.191

8.  Endothelium-dependent and -independent responses to protease-activated receptor-2 (PAR-2) activation in mouse isolated renal arteries.

Authors:  J D Moffatt; T M Cocks
Journal:  Br J Pharmacol       Date:  1998-10       Impact factor: 8.739

9.  P-selectin directs T lymphocyte-mediated injury in delayed-type hypersensitivity responses: studies in glomerulonephritis and cutaneous delayed-type hypersensitivity.

Authors:  P G Tipping; X R Huang; M C Berndt; S R Holdsworth
Journal:  Eur J Immunol       Date:  1996-02       Impact factor: 5.532

10.  Proteinase-activated receptor-2: expression by human neutrophils.

Authors:  G L Howells; M G Macey; C Chinni; L Hou; M T Fox; P Harriott; S R Stone
Journal:  J Cell Sci       Date:  1997-04       Impact factor: 5.285

View more
  13 in total

1.  Cathepsin S-Dependent Protease-Activated Receptor-2 Activation: A New Mechanism of Endothelial Dysfunction.

Authors:  David J Nikolic-Paterson
Journal:  J Am Soc Nephrol       Date:  2015-11-20       Impact factor: 10.121

Review 2.  Update on crescentic glomerulonephritis.

Authors:  Carole Hénique; Christina Papista; Léa Guyonnet; Olivia Lenoir; Pierre-Louis Tharaux
Journal:  Semin Immunopathol       Date:  2014-06-20       Impact factor: 9.623

Review 3.  New insights into sodium transport regulation in the distal nephron: Role of G-protein coupled receptors.

Authors:  Luciana Morla; Aurélie Edwards; Gilles Crambert
Journal:  World J Biol Chem       Date:  2016-02-26

4.  Interleukin-17A promotes early but attenuates established disease in crescentic glomerulonephritis in mice.

Authors:  Dragana Odobasic; Poh-Yi Gan; Shaun A Summers; Tim J Semple; Ruth C M Muljadi; Yoichiro Iwakura; A Richard Kitching; Stephen R Holdsworth
Journal:  Am J Pathol       Date:  2011-07-08       Impact factor: 4.307

5.  Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110).

Authors:  J Y Suen; G D Barry; R J Lohman; M A Halili; A J Cotterell; G T Le; D P Fairlie
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

Review 6.  The emerging role of coagulation proteases in kidney disease.

Authors:  Thati Madhusudhan; Bryce A Kerlin; Berend Isermann
Journal:  Nat Rev Nephrol       Date:  2015-11-23       Impact factor: 28.314

7.  Pathway-selective antagonism of proteinase activated receptor 2.

Authors:  J Y Suen; A Cotterell; R J Lohman; J Lim; A Han; M K Yau; L Liu; M A Cooper; D A Vesey; D P Fairlie
Journal:  Br J Pharmacol       Date:  2014-07-02       Impact factor: 8.739

8.  PR3 and elastase alter PAR1 signaling and trigger vWF release via a calcium-independent mechanism from glomerular endothelial cells.

Authors:  Samantha P Tull; Anne Bevins; Sahithi Jyothsna Kuravi; Simon C Satchell; Bahjat Al-Ani; Stephen P Young; Lorraine Harper; Julie M Williams; George Ed Rainger; Caroline O S Savage
Journal:  PLoS One       Date:  2012-08-29       Impact factor: 3.240

Review 9.  Crescents in primary glomerulonephritis: a pattern of injury with dissimilar actors. A pathophysiologic perspective.

Authors:  Hernán Trimarchi
Journal:  Pediatr Nephrol       Date:  2021-07-27       Impact factor: 3.651

10.  Blood pressures, heart rate and locomotor activity during salt loading and angiotensin II infusion in protease-activated receptor 2 (PAR2) knockout mice.

Authors:  John J McGuire; Bruce N Van Vliet; Sarah J Halfyard
Journal:  BMC Physiol       Date:  2008-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.